Yes, many patients take anticoagulants alongside semaglutide
I think that probably the predominant factor that will drive changes in life expectancy over the next 5 to 10 years will be better treatment of obesity with GLP-1 receptor agonists and related agents. Given the potentially huge health benefits of these diabetes and weight loss drugs, should insurers and government programs such as Medicaid widely cover their use
In fact, its weight loss side effect is why it has become so popularly prescribed off-label for weight loss
BPC 157, short for Body Protective Compound-157, is a synthetic peptide derived from a naturally occurring protein in the stomach called Gastric Juice Protein
Some employers view GLP-1 coverage as part of a broader population health strategy aimed at reducing downstream medical costs and improving workforce health
If you're ready to see if this approach is the right fit for you, our process is simple and straightforward